MedPacto Receives 1.5 Billion Won in Support for Phase 1 Clinical Trial of Innovative MP2021 Drug
MedPacto Selected for National New Drug Development Project MedPacto, a biopharmaceutical company, announced on the 4th that their innovative new drug candidate, ‘MP2021’, aimed at treating bone disease, has been selected for the ‘3rd National New Drug Development Project 2023 New Non-Clinical Drug Development Stage Support Project’ hosted by the Korea New Drug Development Foundation […]
MedPacto Identifies Protein Affecting Bone-Destroying Osteoclasts and Develops New Drug Candidate
Breakthrough in Bone Disease Research: New Protein Identified In a groundbreaking discovery, a protein that affects the development of bone diseases, including osteoporosis, has been identified for the first time. This discovery has paved the way for the development of a new drug candidate targeting the protein, offering hope for the treatment of bone diseases. […]
“Health Net” Prevention of Osteoporosis and Fracture Medical Education “Do This” to Protect Bone Costs and Reduce Risk- Free Health Net
The doctor said that a balanced diet is mainly to ensure sufficient calcium and vitamin D intake to reduce the occurrence of osteoporosis; the picture shows the situation. (picture taken from freepik) [Health Channel/Comprehensive Report]Osteoporosis is a silent disease. According to the statistics of the National Health Administration, about 1 in 7 people over the […]
